{"id":"https://openalex.org/W2007006038","doi":"https://doi.org/10.1002/ijc.1427","title":"2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: A novel class of antitumor agents","display_name":"2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: A novel class of antitumor agents","alternate_titles":[],"publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W2007006038","doi":"https://doi.org/10.1002/ijc.1427","mag":"2007006038","pmid":"https://pubmed.ncbi.nlm.nih.gov/11668483"},"language":"en","primary_location":{"id":"doi:10.1002/ijc.1427","doi":"https://doi.org/10.1002/ijc.1427","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ijc.1427","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.1427","source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007006038"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.1427","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038868084","display_name":"Johnny Easmon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Johnny Easmon","raw_affiliation_strings":["Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028477277","display_name":"Gerhard Puerstinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerhard Puerstinger","raw_affiliation_strings":["Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086812053","display_name":"Thomas F. Roth","orcid":"https://orcid.org/0000-0002-4688-4433","observed_orcids":["https://orcid.org/0000-0002-4688-4433"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Roth","raw_affiliation_strings":["Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062304427","display_name":"Heinz\u2010Herbert Fiebig","orcid":"https://orcid.org/0000-0001-6222-7321","observed_orcids":["https://orcid.org/0000-0001-6222-7321"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heinz-Herbert Fiebig","raw_affiliation_strings":["Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotest GmbH, Institute of Experimental Oncology, Freiburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112828320","display_name":"Marcel Jenny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcel Jenny","raw_affiliation_strings":["Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018012616","display_name":"Walter Jaeger","orcid":"https://orcid.org/0000-0002-4970-8179","observed_orcids":["https://orcid.org/0000-0002-4970-8179"]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Walter Jaeger","raw_affiliation_strings":["Institute of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000795211","display_name":"Gottfried Heinisch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gottfried Heinisch","raw_affiliation_strings":["Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109231201","display_name":"Johann Hofmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Johann Hofmann","raw_affiliation_strings":["Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109231201"],"corresponding_institution_ids":["https://openalex.org/I190249584"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":null,"fwci":1.2042,"has_fulltext":true,"cited_by_count":99,"citation_normalized_percentile":{"value":0.71873676,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"94","issue":"1","first_page":"89","last_page":"96"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9049999713897705},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/xenograft-tumor-growth-inhibition","display_name":"xenograft tumor growth inhibition","score":0.6570000052452087},{"id":"https://openalex.org/keywords/thiosemicarbazones","display_name":"thiosemicarbazones","score":0.7739999890327454},{"id":"https://openalex.org/keywords/ribonucleotide-reductase","display_name":"ribonucleotide reductase","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hydroxyurea-resistance","display_name":"hydroxyurea resistance","score":0.8270000219345093},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C4710235","wikidata":"https://www.wikidata.org/wiki/Q420089","display_name":"Ribonucleotide reductase","level":4,"score":0.8428529500961304},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.5677053928375244},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5226568579673767},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5132594108581543},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.5014851093292236},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.47515177726745605},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4247158169746399},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4130808115005493},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40839242935180664},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4041610658168793},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.37664416432380676},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36427322030067444},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3206658959388733},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.28014224767684937},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007624","descriptor_name":"KB Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ijc.1427","doi":"https://doi.org/10.1002/ijc.1427","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ijc.1427","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.1427","source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:11668483","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11668483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/ijc.1427","doi":"https://doi.org/10.1002/ijc.1427","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ijc.1427","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.1427","source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321181","display_name":"Austrian Science Fund","ror":"https://ror.org/013tf3c58"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2007006038.pdf","grobid_xml":"https://content.openalex.org/works/W2007006038.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W954280178","https://openalex.org/W1528171357","https://openalex.org/W1540828223","https://openalex.org/W1894026278","https://openalex.org/W1975646386","https://openalex.org/W1979129905","https://openalex.org/W1997098467","https://openalex.org/W2015968307","https://openalex.org/W2016954185","https://openalex.org/W2021491682","https://openalex.org/W2041244673","https://openalex.org/W2046673025","https://openalex.org/W2048956687","https://openalex.org/W2073254297","https://openalex.org/W2075749214","https://openalex.org/W2079137496","https://openalex.org/W2109689528","https://openalex.org/W2114918609","https://openalex.org/W2138132734","https://openalex.org/W2167395325","https://openalex.org/W2322477025","https://openalex.org/W2401833113","https://openalex.org/W2404149874","https://openalex.org/W2408391487","https://openalex.org/W2413726875","https://openalex.org/W4236605185","https://openalex.org/W4253186968"],"related_works":["https://openalex.org/W1713433732","https://openalex.org/W2062419532","https://openalex.org/W2146126160","https://openalex.org/W2018546419","https://openalex.org/W2073254297","https://openalex.org/W4379646389","https://openalex.org/W3130530455","https://openalex.org/W2095501114","https://openalex.org/W3044689521","https://openalex.org/W2055622791"],"abstract_inverted_index":{"Here":[0],"we":[1],"describe":[2],"the":[3,37,42,52,98,134,137,142,150,158,179,190,200,208,220,231],"effects":[4],"of":[5,21,36,67,81,100,122,136,145,162,174,176,181,222,230,241,249],"novel":[6,38,138,159,201,237,247],"benzoxazol-2-yl":[7],"and":[8,14,32,60,75,147,203,214,244],"benzimidazol-2-yl":[9],"hydrazones":[10],"derived":[11,113],"from":[12,114],"2-pyridinecarbaldehyde":[13],"2-acetylpyridine.":[15],"The":[16,95,126],"IC(50)":[17],"values":[18],"for":[19],"inhibition":[20,66,80,161,175,240],"cell":[22,177,182],"proliferation":[23],"in":[24,41,105,108,185],"KB-3-1,":[25],"CCRF-CEM,":[26],"Burkitt's":[27],"lymphoma,":[28],"HT-29,":[29],"HeLa,":[30],"ZR-75":[31],"MEXF276L":[33],"by":[34,189],"most":[35],"compounds":[39,53,210,224,238],"are":[40,154],"nanomolar":[43],"range.":[44],"In":[45],"colony-forming":[46],"assays":[47],"with":[48,86,199,207],"human":[49,87,101],"tumor":[50],"xenografts":[51,104],"2-actylpyridine":[54],"benzoxazol-2-ylhydrazone":[55,216],"(EPH52),":[56],"2-acetylpyridine":[57,61],"benzoimidazol-2-ylhydrazone":[58],"(EPH61)":[59],"1-methylbenzoimidazol-2-ylhydrazone":[62],"(EPH116)":[63],"exhibited":[64,78],"above-average":[65,79],"colon":[68,102,242],"carcinoma":[69],"(IC(50)":[70],"=":[71],"1.3-4.56":[72],"nM);":[73],"EPH52":[74],"EPH116":[76,90],"also":[77],"melanoma":[82],"cells.":[83],"As":[84],"shown":[85,118],"liver":[88],"microsomes,":[89],"is":[91,132,194,225],"only":[92],"moderately":[93],"metabolized.":[94],"compound":[96],"inhibited":[97],"growth":[99],"cancer":[103],"nude":[106],"mice":[107],"a":[109,204,246],"dose-dependent":[110],"manner.":[111],"Thiosemicarbazones":[112],"2-formylpyridines":[115],"have":[116],"been":[117],"to":[119,149,157,167,228],"be":[120],"inhibitors":[121],"ribonucleotide":[123],"reductase":[124],"(RR).":[125],"following":[127],"results":[128],"show":[129,239],"that":[130,173,219],"RR":[131,146,151,163,191],"not":[133,155,195,226],"target":[135],"compounds:":[139],"cells":[140],"overexpressing":[141],"M2":[143],"subunit":[144],"resistant":[148],"inhibitor":[152,192],"hydroxyurea":[153,193],"cross-resistant":[156],"compounds;":[160,202],"occurs":[164],"at":[165],"6-":[166],"73-fold":[168],"higher":[169],"drug":[170],"concentrations":[171],"than":[172],"proliferation;":[178],"pattern":[180,221],"cycle":[183],"arrest":[184],"S":[186],"phase":[187],"induced":[188],"observed":[196],"after":[197],"treatment":[198],"COMPARE":[205],"analysis":[206],"related":[209,227],"2-acetylpyrazine":[211],"benzothiazol-2-ylhydrazone":[212],"(EPH95)":[213],"3-acetylisoquinoline":[215],"(EPH136)":[217],"showed":[218],"these":[223,236],"any":[229],"standard":[232],"antitumor":[233],"drugs.":[234],"Therefore,":[235],"cancers":[243],"exhibit":[245],"mechanism":[248],"action.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007006038","counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
